MediPal Holdings Corporation
7459.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥3,671,328 | ¥3,558,732 | ¥3,360,008 | ¥3,290,921 |
| % Growth | 3.2% | 5.9% | 2.1% | – |
| Cost of Goods Sold | ¥3,429,083 | ¥3,312,077 | ¥3,135,703 | ¥3,073,476 |
| Gross Profit | ¥242,245 | ¥246,655 | ¥224,305 | ¥217,445 |
| % Margin | 6.6% | 6.9% | 6.7% | 6.6% |
| R&D Expenses | ¥0 | ¥991 | ¥103 | ¥108 |
| G&A Expenses | ¥0 | ¥164,212 | ¥144,338 | ¥140,870 |
| SG&A Expenses | ¥23,593 | ¥184,686 | ¥163,143 | ¥159,487 |
| Sales & Mktg Exp. | ¥23,593 | ¥20,474 | ¥18,805 | ¥18,617 |
| Other Operating Expenses | ¥163,041 | ¥13,648 | ¥12,082 | ¥12,223 |
| Operating Expenses | ¥186,634 | ¥199,325 | ¥175,328 | ¥171,818 |
| Operating Income | ¥55,611 | ¥47,331 | ¥48,972 | ¥45,624 |
| % Margin | 1.5% | 1.3% | 1.5% | 1.4% |
| Other Income/Exp. Net | ¥21,123 | ¥27,410 | ¥21,089 | ¥11,660 |
| Pre-Tax Income | ¥76,734 | ¥74,741 | ¥70,061 | ¥57,284 |
| Tax Expense | ¥25,203 | ¥22,973 | ¥21,738 | ¥18,087 |
| Net Income | ¥40,280 | ¥41,474 | ¥38,806 | ¥29,423 |
| % Margin | 1.1% | 1.2% | 1.2% | 0.9% |
| EPS | 193.19 | 195.83 | 184.82 | 140.13 |
| % Growth | -1.3% | 6% | 31.9% | – |
| EPS Diluted | 193.19 | 195.83 | 179.12 | 131.41 |
| Weighted Avg Shares Out | 208 | 212 | 210 | 210 |
| Weighted Avg Shares Out Dil | 208 | 212 | 216 | 223 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥50 | ¥29 | ¥101 | ¥177 |
| Interest Expense | ¥7 | ¥8 | ¥34 | ¥16 |
| Depreciation & Amortization | ¥18,417 | ¥17,982 | ¥14,648 | ¥14,338 |
| EBITDA | ¥95,161 | ¥92,731 | ¥84,743 | ¥71,638 |
| % Margin | 2.6% | 2.6% | 2.5% | 2.2% |